PortfoliosLab logo
IDXX vs. EXAS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between IDXX and EXAS is 0.54, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.5

Performance

IDXX vs. EXAS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in IDEXX Laboratories, Inc. (IDXX) and Exact Sciences Corporation (EXAS). The values are adjusted to include any dividend payments, if applicable.

0.00%2,000.00%4,000.00%6,000.00%8,000.00%December2025FebruaryMarchAprilMay
8,169.82%
214.40%
IDXX
EXAS

Key characteristics

Sharpe Ratio

IDXX:

-0.20

EXAS:

-0.34

Sortino Ratio

IDXX:

-0.07

EXAS:

-0.12

Omega Ratio

IDXX:

0.99

EXAS:

0.98

Calmar Ratio

IDXX:

-0.14

EXAS:

-0.27

Martin Ratio

IDXX:

-0.38

EXAS:

-0.81

Ulcer Index

IDXX:

17.62%

EXAS:

24.38%

Daily Std Dev

IDXX:

32.93%

EXAS:

59.05%

Max Drawdown

IDXX:

-81.46%

EXAS:

-98.01%

Current Drawdown

IDXX:

-33.21%

EXAS:

-69.58%

Fundamentals

Market Cap

IDXX:

$35.06B

EXAS:

$8.48B

EPS

IDXX:

$10.66

EXAS:

-$5.59

PEG Ratio

IDXX:

3.71

EXAS:

-1.07

PS Ratio

IDXX:

9.00

EXAS:

3.07

PB Ratio

IDXX:

22.20

EXAS:

3.46

Total Revenue (TTM)

IDXX:

$2.93B

EXAS:

$2.12B

Gross Profit (TTM)

IDXX:

$1.79B

EXAS:

$1.43B

EBITDA (TTM)

IDXX:

$940.32M

EXAS:

-$753.42M

Returns By Period

In the year-to-date period, IDXX achieves a 14.01% return, which is significantly higher than EXAS's -16.07% return. Over the past 10 years, IDXX has outperformed EXAS with an annualized return of 21.92%, while EXAS has yielded a comparatively lower 6.81% annualized return.


IDXX

YTD

14.01%

1M

12.62%

6M

15.84%

1Y

0.71%

5Y*

11.77%

10Y*

21.92%

EXAS

YTD

-16.07%

1M

8.54%

6M

-31.58%

1Y

-21.41%

5Y*

-9.05%

10Y*

6.81%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

IDXX vs. EXAS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IDXX
The Risk-Adjusted Performance Rank of IDXX is 4040
Overall Rank
The Sharpe Ratio Rank of IDXX is 4141
Sharpe Ratio Rank
The Sortino Ratio Rank of IDXX is 3636
Sortino Ratio Rank
The Omega Ratio Rank of IDXX is 3535
Omega Ratio Rank
The Calmar Ratio Rank of IDXX is 4444
Calmar Ratio Rank
The Martin Ratio Rank of IDXX is 4444
Martin Ratio Rank

EXAS
The Risk-Adjusted Performance Rank of EXAS is 3434
Overall Rank
The Sharpe Ratio Rank of EXAS is 3333
Sharpe Ratio Rank
The Sortino Ratio Rank of EXAS is 3434
Sortino Ratio Rank
The Omega Ratio Rank of EXAS is 3434
Omega Ratio Rank
The Calmar Ratio Rank of EXAS is 3535
Calmar Ratio Rank
The Martin Ratio Rank of EXAS is 3434
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

IDXX vs. EXAS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for IDEXX Laboratories, Inc. (IDXX) and Exact Sciences Corporation (EXAS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for IDXX, currently valued at -0.20, compared to the broader market-2.00-1.000.001.002.003.00
IDXX: -0.20
EXAS: -0.34
The chart of Sortino ratio for IDXX, currently valued at -0.07, compared to the broader market-6.00-4.00-2.000.002.004.00
IDXX: -0.07
EXAS: -0.12
The chart of Omega ratio for IDXX, currently valued at 0.99, compared to the broader market0.501.001.502.00
IDXX: 0.99
EXAS: 0.98
The chart of Calmar ratio for IDXX, currently valued at -0.14, compared to the broader market0.001.002.003.004.005.00
IDXX: -0.14
EXAS: -0.27
The chart of Martin ratio for IDXX, currently valued at -0.38, compared to the broader market-10.000.0010.0020.00
IDXX: -0.38
EXAS: -0.81

The current IDXX Sharpe Ratio is -0.20, which is higher than the EXAS Sharpe Ratio of -0.34. The chart below compares the historical Sharpe Ratios of IDXX and EXAS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.80-0.60-0.40-0.200.000.20December2025FebruaryMarchAprilMay
-0.20
-0.34
IDXX
EXAS

Dividends

IDXX vs. EXAS - Dividend Comparison

Neither IDXX nor EXAS has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

IDXX vs. EXAS - Drawdown Comparison

The maximum IDXX drawdown since its inception was -81.46%, smaller than the maximum EXAS drawdown of -98.01%. Use the drawdown chart below to compare losses from any high point for IDXX and EXAS. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%December2025FebruaryMarchAprilMay
-33.21%
-69.58%
IDXX
EXAS

Volatility

IDXX vs. EXAS - Volatility Comparison

IDEXX Laboratories, Inc. (IDXX) and Exact Sciences Corporation (EXAS) have volatilities of 17.69% and 18.50%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%December2025FebruaryMarchAprilMay
17.69%
18.50%
IDXX
EXAS

Financials

IDXX vs. EXAS - Financials Comparison

This section allows you to compare key financial metrics between IDEXX Laboratories, Inc. and Exact Sciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


200.00M400.00M600.00M800.00M1.00BAprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
954.29M
713.42M
(IDXX) Total Revenue
(EXAS) Total Revenue
Values in USD except per share items